Company Product Description Indication Status
Clinuvel Pharmaceuticals Ltd., of Melbourne, Australia Scenesse (afamelanotide) Melanocyte stimulating hormone ligand Erythropoietic protoporphyria Drug added to the national health basket of products reimbursable in Israel
Genmab A/S, of Copenhagen, and Seagen Inc., of Bothell, Wash. Tisotumab vedotin Antibody-drug conjugate targeting tissue factor Recurrent or metastatic cervical cancer with disease progression on or after chemotherapy Submitted BLA to the FDA
Moderna Inc., of Cambridge, Mass. COVID-19 Vaccine Moderna mRNA-based vaccine COVID-19 prophylaxis Qatar Ministry of Public Health issued an emergency use authorization
Oryzon Genomics SA, of Madrid Iadademstat  LSD1 inhibitor Acute myeloid leukemia FDA granted orphan drug designation
Polaryx Therapeutics Inc., of Paramus, N.J. PLX-300 Deaminated product of phenylalanine Krabbe disease FDA granted rare pediatric and orphan drug designations

Notes

For more information about individual companies and/or products, see Cortellis.